V. Cortina

Inhibitors in haemophilia A: current management and open issues

A. Cid, J. Aznar, A. Moret, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

One‐stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

A. Cid, J. Aznar, A. Moret, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation

A. Cid, J. Aznar, N. Cabrera, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Haemophilia in Spain

V. Jiménez‐Yuste, J. Batlle, R. Parra, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol)

A. Cid, J. Aznar, S. Haya, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

The national registry of haemophilia A and B in Spain: results from a census of patients

J. Aznar, J A Aznar, L Abad-Franch, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Evolutional development of the hemostasis laboratory and the treatment of hemophilia.

V. Cortina, 2022, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Diagnostic delay in acquired haemophilia: Analysis of causes and consequences in a 20‐year Spanish cohort

C. Altisent, R. Parra, J. Pardos-Gea, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Severe and moderate hemophilia A: identification of 38 new genetic alterations

A. Cid, J. Aznar, N. Cabrera, 2008, Haematologica.

Variable readthrough responsiveness of nonsense mutations in hemophilia A

J. Barquinero, R. Parra, F. Vidal, 2019, Haematologica.